Wearable Medical Devices Market to grow by USD 15.54 billion from 2022 to 2027 | Market is Fragmented Due to the Presence of Prominent Companies Like Abbott Laboratories, Alphabet Inc., Apple Inc. & More

Wearable Medical Devices Market

The wearable medical devices market is estimated to grow by USD 15.54 billion from 2022 to 2027, growing at a CAGR of 17.82%. The wearable medical devices market is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer wearable medical devices market are 3L Labs Co. Ltd., Abbott Laboratories, Alphabet Inc., Apple Inc., Biotricity Inc., Boston Scientific Corp., Daifuku Co. Ltd., Dexcom Inc., Garmin Ltd., General Electric Co., Huawei Technologies Co. Ltd., Johari Digital India Ltd., Koninklijke Philips N.V., Medtronic Plc, OMRON Corp., Oura Health Oy, Polar Electro Oy, Samsung Electronics Co. Ltd., The Sotera Wireless Inc., and ten3T Healthcare.

The report provides a full list of key companies, their strategies, and the latest developments.

Company Offering:

  • Abbott Laboratories – The company offers wearable medical devices such as wearable FreeStyle Libre devices.
  • Alphabet Inc. – The company offers wearable medical devices such as the Fitbit series under its subsidiary called Google LLC.
  • Apple Inc. – The company offers wearable medical devices such as the Apple Watch series to measure blood oxygen levels.
  • For details on companies and their offerings – Buy the report!

By Geography, the market is classified as North America, Europe, Asia, and Rest of World (ROW). North America will have the largest share of the market. The region is estimated to contribute 37% to the growth of the global market during the forecast period. The rising incidence of diseases, a high prevalence of hearing impairment, an increase in the number of technological devices used for wearables, increasing GDP, increased healthcare spending, new product launches and significant market presence of large companies are some of the major factors driving the growth in the region.

  • Impactful driver- Increasing prevalence of chronic diseases globally
  • Key Trend – Emergence of innovative wearable medical devices
  • Major Challenges – High cost of wearable medical devices

Market Segmentation

  • The diagnostic and monitoring devices segment is estimated to witness significant growth during the forecast period. These devices enable the detection and monitoring of changes in body signatures throughout various areas and organs, thus making them a major advantage. Furthermore, factors such as the increasing health consciousness among end-users, the launch of low-cost wearable vital signs and activity monitoring devices, and technological advancements are also positively impacting the growth of this segment.
  • Related Reports:The diagnostic wearable medical devices market size is estimated to grow by USD 7,333.3 million at a CAGR of 15.2% between 2022 and 2027.The wearable pulse oximeters market is estimated to grow by USD 244.66 million at a CAGR of 7.3% between 2023 and 2027.
SourceTechnavio

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.